Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
XLO
XLO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
XLO News
Xilio Therapeutics Grants Stock Options to New Employees
Mar 02 2026
Newsfilter
Xilio Therapeutics Launches Pre-Funded Warrant Offering
Feb 12 2026
seekingalpha
Xilio Therapeutics Prices Pre-Funded Warrant Offering
Feb 12 2026
Newsfilter
Xilio Therapeutics, Inc. (XLO) Announces Q3 Loss and Falls Short of Revenue Projections
Nov 13 2025
NASDAQ.COM
Xilio Therapeutics Unveils Late-Breaking Phase 2 Results for Vilastobart in MSS mCRC Patients with Elevated Plasma Tumor Mutational Burden at the 40th Annual SITC Meeting
Nov 07 2025
Newsfilter
Xilio Therapeutics to Showcase Phase 2 Data on Vilastobart's Response Rate in MSS mCRC Patients with High Plasma Tumor Mutational Burden in Late-Breaking Presentation at SITC 40th Annual Meeting
Oct 30 2025
Newsfilter
Xilio Therapeutics Reveals Inducement Grants in Accordance with Nasdaq Listing Rule 5635(c)(4)
Oct 02 2025
Newsfilter
Biotech Surge on Friday: Clinical Advancements Drive Afternoon Gains
Sep 29 2025
NASDAQ.COM
Xilio Therapeutics Launches Phase 2 Trial for Efarindodekin Alfa (XTX301), a Tumor-Activated IL-12, and Reaches $17.5 Million Development Milestone in Exclusive Partnership with Gilead
Sep 09 2025
Newsfilter
Catalyst Pharmaceuticals Appoints Daniel Curran, MD, to its Board of Directors
Aug 04 2025
Globenewswire
Bristol Myers Squibb and Bain Capital Form New Immunology Company
Jul 28 2025
WSJ
Xilio Therapeutics Appoints Akintunde Bello, Ph.D., to Board of Directors
Jun 10 2025
NASDAQ.COM
Xilio Therapeutics Announces Closing of $50.0 Million Public Offering
Jun 05 2025
Newsfilter
Xilio Therapeutics Announces $50 Million Public Offering and Potential $150 Million in Total Gross Proceeds
Jun 05 2025
NASDAQ.COM
Nasdaq Edges Higher; ISM Manufacturing PMI Falls In May
Jun 02 2025
Benzinga
Dow Dips Over 300 Points; Campbell's Posts Upbeat Earnings
Jun 02 2025
Benzinga
Show More News
